Alpha GPC 300 mg

Alpha GPC 300 mg

NOW4.6 (6,118 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 30 servings
Goals

Product analysis

59 out of 100

Alpha GPC 300 mg offers a focused choline-related ingredient with preliminary attention and cognitive-support evidence. Unspecified active-content details limit how confidently the declared serving can be matched to that evidence.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The alpha-GPC preparation and active-content basis are not specified. That makes equivalence with precisely defined preparations uncertain.

Ingredient Transparency63

The declared amount permits a basic serving comparison. Missing preparation detail leaves uncertainty about the active-content basis behind that amount.

Value For Money100

The declared serving compares favorably on cost. Unverified active-content detail limits how directly that price can be compared with precisely specified preparations.

Customer Satisfaction87

Ratings show positive satisfaction across a large number of responses. The broad response provides a more established picture of satisfaction without establishing cognitive effects.

Product Focus53

The single ingredient keeps the formula centered on choline-related brain functions. Attention and cognitive evidence remains preliminary and tied to specific preparations and short-term testing.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.79
Customer rating
4.6 · 6,118 ratings
Report analysis

Goals

Productivity Boost
Impact
Lower effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 600 mg
Study evidence
Alpha-GPC Supportive 2 studies
Mental Focus
Impact
Lower effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 600 mg
Study evidence
Alpha-GPC Supportive 1 study
Cognitive Support
Impact
Moderate effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 600 mg
Study evidence
Alpha-GPC Supportive 15 studies
Brain Health
Impact
High effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 600 mg
Study evidence
Alpha-GPC Supportive 12 studies
Longevity
Impact
Lower effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 600 mg
Study evidence
Alpha-GPC Not classified

No linked studies yet.

Ingredients

IngredientAmount per servingScore
Alpha GPC
600 mg 80
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
Alpha-GPC · 600 mg OverallScore80
B- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
The serving provides 600 mg of Alpha-GPC, with a low cost for the amount. The Alpha-GPC has a stated botanical source, though its identity is not specified in the available details. The active amount is stated, but a separate yield is not.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

The Alpha-GPC has a stated botanical source, though its identity is not specified in the available details.
Patented/Branded Form and Source
The Alpha-GPC has a stated botanical source, though its identity is not specified in the available details.

Dose, Safety & Label Transparency80

A serving provides 600 mg of Alpha-GPC. A separate active-yield statement is not available.
Active Alpha-GPC Dosage
The stated active Alpha-GPC amount is 600 mg per serving.
Label Transparency & Yield Disclosure
The active amount is stated, but a separate active-yield statement is not available.

Value100

The cost for the stated Alpha-GPC amount is low.
Price per 300mg Active Alpha-GPC
The cost per 300 mg of Alpha-GPC is low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledBrain Health Cognitive Support forAlpha-GPC
  2. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsBrain Health Cognitive Support forAlpha-GPC
  3. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsBrain Health Cognitive Support forAlpha-GPC
  4. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
    Kerksick CM · Nutrients · 2024
    Randomized trial20 participantsBrain Health Mental Focus Productivity Boost forAlpha-GPC
  5. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsBrain Health forAlpha-GPC
  6. [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
    Voznyuk IA; Nepomnyashchiy IS; Kutkova AK; Tokareva DV; Prokhorova MV; Ovdiienko OA; Shusharina NN · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
    Meta-analysis10 studies pooledCognitive Support forAlpha-GPC
  7. Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
    Guan F; Jia X; Huang F; Zhang J; Wei Y; Li L; Bai J; Wang H · Nutrients · 2024
    Cohort study7,659 participantsCognitive Support forAlpha-GPC
  8. Treatment of dementia with neurotransmission modulation.
    Doggrell SA; Evans S · Expert opinion on investigational drugs · 2004
    Narrative reviewProductivity Boost forAlpha-GPC